FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3090841837> ?p ?o ?g. }

• W3090841837 endingPage "567" @default.
• W3090841837 startingPage "567" @default.
• W3090841837 abstract "Cyprinid herpesvirus 2 (CyHV-2) infection results in huge economic losses in gibel carp (Carassius auratus gibelio) industry. In this study, we first constructed recombinant plasmids pcORF25 and pcCCL35.2 as DNA vaccine and molecular adjuvant against CyHV-2, respectively, and confirmed that both recombinant plasmids could be effectively expressed in vitro and in vivo. Then, the vaccination and infection experiments (n = 50) were set as seven groups. The survival rate (70%) in ORF25/CCL35.2 group was highest. The highest specific antibody levels were found in ORF25/CCL35.2 group in major immune tissues by qRT-PCR, and confirmed in serum by ELISA assay, antibody neutralization titer, and serum incubation-infection experiments. Three crucial innate immune indices, namely C3 content, lysozyme, and total superoxide dismutase (TSOD) activities, were highest in ORF25/CCL35.2 group in serum. pcORF25/pcCCL35.2 can effectively up-regulate mRNA expressions of some important immune genes (IL-1β, IL-2, IFN-γ2, and viperin), and significantly suppress CyHV-2 replication in head kidney and spleen tissues. The minimal tissue lesions can be seen in ORF25/CCL35.2 group in gill, spleen, and trunk kidney tissues by histopathological examination. The results indicated that the combination of DNA vaccine pcORF25 and molecular adjuvant pcCCL35.2 is an effective method against CyHV-2 infection, suggesting a feasible strategy for the control of fish viral diseases." @default.
• W3090841837 created "2020-10-08" @default.
• W3090841837 creator A5041920269 @default.
• W3090841837 creator A5048942547 @default.
• W3090841837 creator A5067581467 @default.
• W3090841837 creator A5090726736 @default.
• W3090841837 date "2020-10-01" @default.
• W3090841837 modified "2023-10-16" @default.
• W3090841837 title "The Combination of Molecular Adjuvant CCL35.2 and DNA Vaccine Significantly Enhances the Immune Protection of Carassius auratus gibelio against CyHV-2 Infection" @default.
• W3090841837 cites W1513604776 @default.
• W3090841837 cites W1966288604 @default.
• W3090841837 cites W1975105353 @default.
• W3090841837 cites W1975662202 @default.
• W3090841837 cites W1993249814 @default.
• W3090841837 cites W1997913517 @default.
• W3090841837 cites W2012576126 @default.
• W3090841837 cites W2033627894 @default.
• W3090841837 cites W2051105738 @default.
• W3090841837 cites W2055613006 @default.
• W3090841837 cites W2057901653 @default.
• W3090841837 cites W2060697801 @default.
• W3090841837 cites W2062934605 @default.
• W3090841837 cites W2064801970 @default.
• W3090841837 cites W2065818546 @default.
• W3090841837 cites W2070556075 @default.
• W3090841837 cites W2078664576 @default.
• W3090841837 cites W2081773180 @default.
• W3090841837 cites W2083532018 @default.
• W3090841837 cites W2085182827 @default.
• W3090841837 cites W2093655846 @default.
• W3090841837 cites W2103827956 @default.
• W3090841837 cites W2133623475 @default.
• W3090841837 cites W2145866317 @default.
• W3090841837 cites W2153739002 @default.
• W3090841837 cites W2161733113 @default.
• W3090841837 cites W2190567753 @default.
• W3090841837 cites W2330259340 @default.
• W3090841837 cites W2612117698 @default.
• W3090841837 cites W2625571305 @default.
• W3090841837 cites W2756901651 @default.
• W3090841837 cites W2782993341 @default.
• W3090841837 cites W2807254729 @default.
• W3090841837 cites W2836866101 @default.
• W3090841837 cites W2884203362 @default.
• W3090841837 cites W2889606291 @default.
• W3090841837 cites W2909089251 @default.
• W3090841837 cites W2912245470 @default.
• W3090841837 cites W2938316375 @default.
• W3090841837 cites W2947335319 @default.
• W3090841837 cites W2948736903 @default.
• W3090841837 cites W2972271796 @default.
• W3090841837 cites W2999365069 @default.
• W3090841837 cites W3006405987 @default.
• W3090841837 cites W3017763356 @default.
• W3090841837 cites W3041212845 @default.
• W3090841837 doi "https://doi.org/10.3390/vaccines8040567" @default.
• W3090841837 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7712643" @default.
• W3090841837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33019519" @default.
• W3090841837 hasPublicationYear "2020" @default.
• W3090841837 type Work @default.
• W3090841837 sameAs 3090841837 @default.
• W3090841837 citedByCount "23" @default.
• W3090841837 countsByYear W30908418372021 @default.
• W3090841837 countsByYear W30908418372022 @default.
• W3090841837 countsByYear W30908418372023 @default.
• W3090841837 crossrefType "journal-article" @default.
• W3090841837 hasAuthorship W3090841837A5041920269 @default.
• W3090841837 hasAuthorship W3090841837A5048942547 @default.
• W3090841837 hasAuthorship W3090841837A5067581467 @default.
• W3090841837 hasAuthorship W3090841837A5090726736 @default.
• W3090841837 hasBestOaLocation W30908418371 @default.
• W3090841837 hasConcept C104317684 @default.
• W3090841837 hasConcept C153911025 @default.
• W3090841837 hasConcept C159047783 @default.
• W3090841837 hasConcept C159654299 @default.
• W3090841837 hasConcept C167508917 @default.
• W3090841837 hasConcept C203014093 @default.
• W3090841837 hasConcept C22070199 @default.
• W3090841837 hasConcept C22744801 @default.
• W3090841837 hasConcept C22889606 @default.
• W3090841837 hasConcept C2522874641 @default.
• W3090841837 hasConcept C2777863537 @default.
• W3090841837 hasConcept C2780801004 @default.
• W3090841837 hasConcept C2780931953 @default.
• W3090841837 hasConcept C32611913 @default.
• W3090841837 hasConcept C40767141 @default.
• W3090841837 hasConcept C55493867 @default.
• W3090841837 hasConcept C86803240 @default.
• W3090841837 hasConcept C8891405 @default.
• W3090841837 hasConcept C89423630 @default.
• W3090841837 hasConceptScore W3090841837C104317684 @default.
• W3090841837 hasConceptScore W3090841837C153911025 @default.
• W3090841837 hasConceptScore W3090841837C159047783 @default.
• W3090841837 hasConceptScore W3090841837C159654299 @default.
• W3090841837 hasConceptScore W3090841837C167508917 @default.
• W3090841837 hasConceptScore W3090841837C203014093 @default.
• W3090841837 hasConceptScore W3090841837C22070199 @default.
• W3090841837 hasConceptScore W3090841837C22744801 @default.

• next